The biotech start-up is testing therapies that can regenerate poor quality donor livers, to give more people access to better quality organs for transplants.
Read more: Irish-founded Ochre Bio raises $30m to develop liver disease treatments
The biotech start-up is testing therapies that can regenerate poor quality donor livers, to give more people access to better quality organs for transplants.
Read more: Irish-founded Ochre Bio raises $30m to develop liver disease treatments